

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pattern specification involved in kidney development (GO:0061004) | 7.26645549 |
| 2 | negative regulation of complement activation (GO:0045916) | 7.22880930 |
| 3 | cellular response to nitric oxide (GO:0071732) | 7.01257592 |
| 4 | negative regulation of humoral immune response (GO:0002921) | 6.91073238 |
| 5 | negative regulation of protein activation cascade (GO:2000258) | 6.40144893 |
| 6 | response to xenobiotic stimulus (GO:0009410) | 6.18868872 |
| 7 | positive regulation of endothelial cell differentiation (GO:0045603) | 6.02196307 |
| 8 | regulation of endothelial cell differentiation (GO:0045601) | 5.86961844 |
| 9 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.82466110 |
| 10 | axonemal dynein complex assembly (GO:0070286) | 5.75397116 |
| 11 | lung lobe morphogenesis (GO:0060463) | 5.64799225 |
| 12 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.46287774 |
| 13 | cellular response to reactive nitrogen species (GO:1902170) | 5.42778177 |
| 14 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 5.31628684 |
| 15 | one-carbon compound transport (GO:0019755) | 5.29320747 |
| 16 | endothelial tube morphogenesis (GO:0061154) | 5.27614592 |
| 17 | morphogenesis of an endothelium (GO:0003159) | 5.27614592 |
| 18 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 5.19036820 |
| 19 | response to nitric oxide (GO:0071731) | 5.13265768 |
| 20 | regulation of vasculogenesis (GO:2001212) | 4.71876042 |
| 21 | sodium-independent organic anion transport (GO:0043252) | 4.59004727 |
| 22 | respiratory gaseous exchange (GO:0007585) | 4.44438235 |
| 23 | regulation of complement activation (GO:0030449) | 4.41444141 |
| 24 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.30682382 |
| 25 | cilium movement (GO:0003341) | 4.27305430 |
| 26 | peptide catabolic process (GO:0043171) | 4.25763245 |
| 27 | iron ion import (GO:0097286) | 4.08956846 |
| 28 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.06871197 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.04638738 |
| 30 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 4.02712644 |
| 31 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.01975894 |
| 32 | mesodermal cell differentiation (GO:0048333) | 4.00685569 |
| 33 | virion attachment to host cell (GO:0019062) | 4.00027850 |
| 34 | adhesion of symbiont to host cell (GO:0044650) | 4.00027850 |
| 35 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.96735664 |
| 36 | blood vessel maturation (GO:0001955) | 3.96273809 |
| 37 | sphingosine metabolic process (GO:0006670) | 3.89890545 |
| 38 | protein localization to endosome (GO:0036010) | 3.84134920 |
| 39 | lung vasculature development (GO:0060426) | 3.83967564 |
| 40 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.81791712 |
| 41 | hyperosmotic salinity response (GO:0042538) | 3.71755949 |
| 42 | establishment of apical/basal cell polarity (GO:0035089) | 3.69831563 |
| 43 | motile cilium assembly (GO:0044458) | 3.68028632 |
| 44 | hemidesmosome assembly (GO:0031581) | 3.65696707 |
| 45 | segment specification (GO:0007379) | 3.64410528 |
| 46 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.64306207 |
| 47 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.64123853 |
| 48 | respiratory tube development (GO:0030323) | 3.60108609 |
| 49 | endocrine hormone secretion (GO:0060986) | 3.56556098 |
| 50 | positive regulation of p38MAPK cascade (GO:1900745) | 3.55382585 |
| 51 | lung alveolus development (GO:0048286) | 3.46869384 |
| 52 | renal absorption (GO:0070293) | 3.46565228 |
| 53 | sodium ion homeostasis (GO:0055078) | 3.44279280 |
| 54 | regulation of hippo signaling (GO:0035330) | 3.42363376 |
| 55 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.41748654 |
| 56 | adhesion of symbiont to host (GO:0044406) | 3.40841428 |
| 57 | endocardial cushion development (GO:0003197) | 3.40669292 |
| 58 | diol metabolic process (GO:0034311) | 3.40618349 |
| 59 | lymphangiogenesis (GO:0001946) | 3.40582313 |
| 60 | response to vitamin A (GO:0033189) | 3.39143949 |
| 61 | epithelial cilium movement (GO:0003351) | 3.30886141 |
| 62 | ethanol metabolic process (GO:0006067) | 3.30294078 |
| 63 | macrophage chemotaxis (GO:0048246) | 3.28383107 |
| 64 | ethanol oxidation (GO:0006069) | 3.27597927 |
| 65 | cell adhesion mediated by integrin (GO:0033627) | 3.25304052 |
| 66 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.25193725 |
| 67 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.24989951 |
| 68 | embryonic foregut morphogenesis (GO:0048617) | 3.21176158 |
| 69 | complement activation, classical pathway (GO:0006958) | 3.19948334 |
| 70 | negative regulation of interleukin-2 production (GO:0032703) | 3.19765754 |
| 71 | angiotensin maturation (GO:0002003) | 3.19287038 |
| 72 | hormone catabolic process (GO:0042447) | 3.19036419 |
| 73 | artery development (GO:0060840) | 3.18788935 |
| 74 | polyol transport (GO:0015791) | 3.11488893 |
| 75 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.10035136 |
| 76 | establishment of monopolar cell polarity (GO:0061162) | 3.10035136 |
| 77 | regulation of glomerular filtration (GO:0003093) | 3.09819517 |
| 78 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.09777150 |
| 79 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.08979742 |
| 80 | complement activation (GO:0006956) | 3.08003344 |
| 81 | positive regulation of vasculogenesis (GO:2001214) | 3.07742014 |
| 82 | glomerular epithelial cell development (GO:0072310) | 3.03556528 |
| 83 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.02694135 |
| 84 | triglyceride biosynthetic process (GO:0019432) | 3.02227318 |
| 85 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.00466986 |
| 86 | negative regulation of fatty acid transport (GO:2000192) | 3.00254092 |
| 87 | response to hyperoxia (GO:0055093) | 2.99545648 |
| 88 | response to increased oxygen levels (GO:0036296) | 2.99545648 |
| 89 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.97753577 |
| 90 | regulation of p38MAPK cascade (GO:1900744) | 2.97484374 |
| 91 | primary alcohol catabolic process (GO:0034310) | 2.97455623 |
| 92 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.97283103 |
| 93 | import into cell (GO:0098657) | 2.97229936 |
| 94 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.96730764 |
| 95 | regulation of cardioblast differentiation (GO:0051890) | 2.93570002 |
| 96 | branch elongation of an epithelium (GO:0060602) | 2.93567779 |
| 97 | Leydig cell differentiation (GO:0033327) | 2.91573155 |
| 98 | axis elongation (GO:0003401) | 2.90581565 |
| 99 | water homeostasis (GO:0030104) | 2.90418415 |
| 100 | acylglycerol biosynthetic process (GO:0046463) | 2.90290692 |
| 101 | neutral lipid biosynthetic process (GO:0046460) | 2.90290692 |
| 102 | left/right pattern formation (GO:0060972) | 2.89689866 |
| 103 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.88545935 |
| 104 | lung secretory cell differentiation (GO:0061140) | 2.86935138 |
| 105 | negative regulation of B cell mediated immunity (GO:0002713) | 2.86615515 |
| 106 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.86615515 |
| 107 | regulation of interleukin-13 production (GO:0032656) | 2.85491157 |
| 108 | toxin transport (GO:1901998) | 2.84549915 |
| 109 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.83402938 |
| 110 | cellular sodium ion homeostasis (GO:0006883) | 2.81638626 |
| 111 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.81122377 |
| 112 | regulation of humoral immune response (GO:0002920) | 2.80211272 |
| 113 | cellular response to antibiotic (GO:0071236) | 2.79403699 |
| 114 | response to interleukin-6 (GO:0070741) | 2.79364900 |
| 115 | sphingoid metabolic process (GO:0046519) | 2.78662147 |
| 116 | glomerular filtration (GO:0003094) | 2.78640407 |
| 117 | lung-associated mesenchyme development (GO:0060484) | 2.78516364 |
| 118 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.76866964 |
| 119 | positive regulation of digestive system process (GO:0060456) | 2.75607755 |
| 120 | tight junction assembly (GO:0070830) | 2.75258849 |
| 121 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.74811733 |
| 122 | membrane protein proteolysis (GO:0033619) | 2.73656008 |
| 123 | regulation of apoptotic cell clearance (GO:2000425) | 2.72858407 |
| 124 | glomerular visceral epithelial cell development (GO:0072015) | 2.72047041 |
| 125 | protein autoprocessing (GO:0016540) | 2.71265839 |
| 126 | toxin metabolic process (GO:0009404) | 2.70834283 |
| 127 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.70505099 |
| 128 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.70051562 |
| 129 | multicellular organismal water homeostasis (GO:0050891) | 2.68620137 |
| 130 | endothelial cell chemotaxis (GO:0035767) | 2.67926976 |
| 131 | establishment of epithelial cell polarity (GO:0090162) | 2.67544075 |
| 132 | polarized epithelial cell differentiation (GO:0030859) | 2.67102538 |
| 133 | renal filtration (GO:0097205) | 2.65481925 |
| 134 | receptor catabolic process (GO:0032801) | 2.64664893 |
| 135 | axoneme assembly (GO:0035082) | 2.64410116 |
| 136 | striated muscle atrophy (GO:0014891) | 2.63986552 |
| 137 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.63485426 |
| 138 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.61998456 |
| 139 | regulation of tight junction assembly (GO:2000810) | 2.61448094 |
| 140 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.60078154 |
| 141 | protein activation cascade (GO:0072376) | 2.58822409 |
| 142 | thyroid hormone generation (GO:0006590) | 2.57367545 |
| 143 | coronary vasculature morphogenesis (GO:0060977) | 2.57356204 |
| 144 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.56808886 |
| 145 | wound healing, spreading of epidermal cells (GO:0035313) | 2.56321209 |
| 146 | thioester biosynthetic process (GO:0035384) | 2.56141835 |
| 147 | complement activation, alternative pathway (GO:0006957) | 2.53867132 |
| 148 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.51620105 |
| 149 | induction of positive chemotaxis (GO:0050930) | 2.51544689 |
| 150 | negative regulation of stress fiber assembly (GO:0051497) | 2.50758181 |
| 151 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.46431880 |
| 152 | neuron remodeling (GO:0016322) | 2.44026593 |
| 153 | cellular hyperosmotic response (GO:0071474) | 2.42645080 |
| 154 | positive regulation of chemokine secretion (GO:0090197) | 2.42581693 |
| 155 | T cell mediated immunity (GO:0002456) | 2.42182395 |
| 156 | norepinephrine metabolic process (GO:0042415) | 2.41562798 |
| 157 | peptide cross-linking (GO:0018149) | 2.40602814 |
| 158 | fibroblast migration (GO:0010761) | 2.39130306 |
| 159 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.37147458 |
| 160 | apoptotic cell clearance (GO:0043277) | 2.36589391 |
| 161 | lateral ventricle development (GO:0021670) | 2.36357423 |
| 162 | establishment of endothelial barrier (GO:0061028) | 2.35973795 |
| 163 | left/right axis specification (GO:0070986) | 2.35523634 |
| 164 | membrane raft organization (GO:0031579) | 2.34822428 |
| 165 | surfactant homeostasis (GO:0043129) | 18.7510576 |
| 166 | chemical homeostasis within a tissue (GO:0048875) | 15.0169046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.54820740 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.21414198 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.18195536 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00855430 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.97768802 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.82909391 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.72892267 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.70059095 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.66791075 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.66201694 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.61218914 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54663095 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.42684561 |
| 14 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.32797557 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27677251 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24825673 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.14833265 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.10421586 |
| 19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.09451430 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06854964 |
| 21 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.05728222 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.04503458 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.00326028 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.99672320 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95687282 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.92719868 |
| 27 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91933611 |
| 28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.89331862 |
| 29 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.87092525 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86471114 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85070293 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.82400778 |
| 33 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.81300301 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.77860995 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75391973 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.75374324 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71815008 |
| 38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.71543302 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68978933 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67775828 |
| 41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.66736233 |
| 42 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59971136 |
| 43 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.57393288 |
| 44 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.57393288 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56831634 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52240165 |
| 47 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51919382 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50178871 |
| 49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48723775 |
| 50 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46837725 |
| 51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.46317916 |
| 52 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45332563 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45056697 |
| 54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.44685264 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.43530754 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42966648 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42709116 |
| 58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.41758702 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40076237 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39390116 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36448619 |
| 62 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36388936 |
| 63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.35719129 |
| 64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.35526269 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33905988 |
| 66 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.30122882 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29642153 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29642153 |
| 69 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29540433 |
| 70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29122959 |
| 71 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28782335 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27917053 |
| 73 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.27246435 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27048162 |
| 75 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25042331 |
| 76 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24485456 |
| 77 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.24422257 |
| 78 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23848612 |
| 79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22543918 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22498586 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21161949 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20434639 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17914980 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15394278 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15394278 |
| 86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14850595 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.14259651 |
| 88 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12001945 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11572856 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10275182 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09266947 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08110906 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07842194 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07828923 |
| 95 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07620194 |
| 96 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05926426 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04931223 |
| 98 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03918241 |
| 99 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03896187 |
| 100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03822500 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03804710 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02225805 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02209307 |
| 104 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01933932 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99884128 |
| 106 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99733222 |
| 107 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98823075 |
| 108 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98692157 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98612981 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97941292 |
| 111 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97661000 |
| 112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97496031 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97051579 |
| 114 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95622875 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95555709 |
| 116 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93380632 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92011528 |
| 118 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91900484 |
| 119 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.90229390 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89407147 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89333574 |
| 122 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89031772 |
| 123 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88935120 |
| 124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87847997 |
| 125 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87274757 |
| 126 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87061227 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86202254 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83672327 |
| 129 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.82368515 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75590362 |
| 131 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.74899425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 9.80031249 |
| 2 | MP0001958_emphysema | 5.86272023 |
| 3 | MP0008995_early_reproductive_senescence | 4.76621969 |
| 4 | MP0005083_abnormal_biliary_tract | 3.98905260 |
| 5 | MP0008004_abnormal_stomach_pH | 3.68041801 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.38538277 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.11461598 |
| 8 | MP0001177_atelectasis | 2.89064993 |
| 9 | MP0003724_increased_susceptibility_to | 2.87476364 |
| 10 | MP0002133_abnormal_respiratory_system | 2.78084001 |
| 11 | MP0005388_respiratory_system_phenotype | 2.78084001 |
| 12 | MP0002295_abnormal_pulmonary_circulatio | 2.43137951 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.34440513 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.34257733 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.28026625 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.26160053 |
| 17 | MP0000566_synostosis | 2.18285199 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 2.15124516 |
| 19 | MP0001542_abnormal_bone_strength | 2.12104080 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.00283764 |
| 21 | MP0002132_abnormal_respiratory_system | 1.60755846 |
| 22 | MP0004272_abnormal_basement_membrane | 1.58787127 |
| 23 | MP0005503_abnormal_tendon_morphology | 1.51506630 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49719377 |
| 25 | MP0001881_abnormal_mammary_gland | 1.47771066 |
| 26 | MP0005165_increased_susceptibility_to | 1.42923403 |
| 27 | MP0001175_abnormal_lung_morphology | 1.39882399 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.39538455 |
| 29 | MP0009840_abnormal_foam_cell | 1.38859930 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.34652619 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.33473427 |
| 32 | MP0003115_abnormal_respiratory_system | 1.30801428 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.29636310 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.25848917 |
| 35 | MP0003786_premature_aging | 1.21042817 |
| 36 | MP0010678_abnormal_skin_adnexa | 1.20009922 |
| 37 | MP0005408_hypopigmentation | 1.15977583 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.15705799 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.13036460 |
| 40 | MP0002098_abnormal_vibrissa_morphology | 1.07512525 |
| 41 | MP0004883_abnormal_blood_vessel | 1.06243029 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.06025498 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.05948436 |
| 44 | MP0005387_immune_system_phenotype | 1.05614155 |
| 45 | MP0001790_abnormal_immune_system | 1.05614155 |
| 46 | MP0003303_peritoneal_inflammation | 1.04233682 |
| 47 | MP0002796_impaired_skin_barrier | 1.04106705 |
| 48 | MP0005275_abnormal_skin_tensile | 1.03998582 |
| 49 | MP0001851_eye_inflammation | 1.03737737 |
| 50 | MP0000462_abnormal_digestive_system | 1.03615671 |
| 51 | MP0005164_abnormal_response_to | 1.02940882 |
| 52 | MP0000534_abnormal_ureter_morphology | 1.02222571 |
| 53 | MP0004043_abnormal_pH_regulation | 1.01174668 |
| 54 | MP0000627_abnormal_mammary_gland | 1.00199089 |
| 55 | MP0002998_abnormal_bone_remodeling | 0.98495269 |
| 56 | MP0005023_abnormal_wound_healing | 0.97399032 |
| 57 | MP0003690_abnormal_glial_cell | 0.97369300 |
| 58 | MP0000767_abnormal_smooth_muscle | 0.95472779 |
| 59 | MP0010329_abnormal_lipoprotein_level | 0.94389934 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 0.93753565 |
| 61 | MP0006138_congestive_heart_failure | 0.93565449 |
| 62 | MP0000343_altered_response_to | 0.91826718 |
| 63 | MP0000249_abnormal_blood_vessel | 0.91187125 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 0.88107865 |
| 65 | MP0001440_abnormal_grooming_behavior | 0.87975604 |
| 66 | MP0000383_abnormal_hair_follicle | 0.85990956 |
| 67 | MP0003300_gastrointestinal_ulcer | 0.84107151 |
| 68 | MP0006054_spinal_hemorrhage | 0.83954304 |
| 69 | MP0005166_decreased_susceptibility_to | 0.83871417 |
| 70 | MP0001664_abnormal_digestion | 0.83785921 |
| 71 | MP0003091_abnormal_cell_migration | 0.83740889 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 0.83470543 |
| 73 | MP0005595_abnormal_vascular_smooth | 0.83274228 |
| 74 | MP0004484_altered_response_of | 0.80824317 |
| 75 | MP0003045_fibrosis | 0.80300515 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 0.77646012 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 0.76656560 |
| 78 | MP0001545_abnormal_hematopoietic_system | 0.76656560 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.76180527 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.73745217 |
| 81 | MP0004947_skin_inflammation | 0.70939275 |
| 82 | MP0001849_ear_inflammation | 0.70868344 |
| 83 | MP0001943_abnormal_respiration | 0.70019211 |
| 84 | MP0003448_altered_tumor_morphology | 0.69364400 |
| 85 | MP0000013_abnormal_adipose_tissue | 0.66111840 |
| 86 | MP0002405_respiratory_system_inflammati | 0.64892883 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.62998080 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.62476666 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.62438103 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.60820226 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.60738494 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.60304440 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.59488488 |
| 94 | MP0009384_cardiac_valve_regurgitation | 0.57973603 |
| 95 | MP0001853_heart_inflammation | 0.57747564 |
| 96 | MP0002128_abnormal_blood_circulation | 0.57331877 |
| 97 | MP0003828_pulmonary_edema | 0.57269716 |
| 98 | MP0004130_abnormal_muscle_cell | 0.57158501 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.56975506 |
| 100 | MP0002060_abnormal_skin_morphology | 0.56051176 |
| 101 | MP0005025_abnormal_response_to | 0.55980783 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.55377994 |
| 103 | MP0002108_abnormal_muscle_morphology | 0.54781335 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.54630490 |
| 105 | MP0001502_abnormal_circadian_rhythm | 0.54296376 |
| 106 | MP0002168_other_aberrant_phenotype | 0.54222662 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.54027743 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.53183009 |
| 109 | MP0005647_abnormal_sex_gland | 0.52892242 |
| 110 | * MP0002925_abnormal_cardiovascular_devel | 0.52678713 |
| 111 | MP0003329_amyloid_beta_deposits | 0.52249477 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.52202787 |
| 113 | MP0005365_abnormal_bile_salt | 0.52177724 |
| 114 | MP0003075_altered_response_to | 0.52118984 |
| 115 | MP0003279_aneurysm | 0.52082445 |
| 116 | MP0002135_abnormal_kidney_morphology | 0.52062525 |
| 117 | MP0002419_abnormal_innate_immunity | 0.51968128 |
| 118 | MP0005360_urolithiasis | 0.51956140 |
| 119 | MP0008260_abnormal_autophagy | 0.51926989 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.51678428 |
| 121 | MP0003436_decreased_susceptibility_to | 0.51426485 |
| 122 | MP0003890_abnormal_embryonic-extraembry | 0.51363104 |
| 123 | MP0003119_abnormal_digestive_system | 0.50717217 |
| 124 | MP0004019_abnormal_vitamin_homeostasis | 0.50490953 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 0.49752117 |
| 126 | MP0001756_abnormal_urination | 0.49530768 |
| 127 | MP0004084_abnormal_cardiac_muscle | 0.47851712 |
| 128 | * MP0001614_abnormal_blood_vessel | 0.47820419 |
| 129 | MP0004885_abnormal_endolymph | 0.47375330 |
| 130 | MP0000470_abnormal_stomach_morphology | 0.46133022 |
| 131 | MP0008438_abnormal_cutaneous_collagen | 0.45176238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tubulointerstitial fibrosis (HP:0005576) | 6.68140037 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 6.45871038 |
| 3 | Tachypnea (HP:0002789) | 6.33522596 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.06299643 |
| 5 | Respiratory distress (HP:0002098) | 5.73921860 |
| 6 | Chronic bronchitis (HP:0004469) | 5.70753674 |
| 7 | Gout (HP:0001997) | 5.57127802 |
| 8 | Renal salt wasting (HP:0000127) | 5.47811657 |
| 9 | Absent/shortened dynein arms (HP:0200106) | 5.34411100 |
| 10 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.34411100 |
| 11 | Abnormal ciliary motility (HP:0012262) | 5.31592995 |
| 12 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.29198950 |
| 13 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.29198950 |
| 14 | Polycythemia (HP:0001901) | 5.28529413 |
| 15 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.28397772 |
| 16 | Rhinitis (HP:0012384) | 4.99135039 |
| 17 | Neurofibrillary tangles (HP:0002185) | 4.21525624 |
| 18 | Hematochezia (HP:0002573) | 4.20799267 |
| 19 | Onycholysis (HP:0001806) | 4.06431994 |
| 20 | Hyperkalemia (HP:0002153) | 4.05889423 |
| 21 | Abnormality of the fingertips (HP:0001211) | 4.03155484 |
| 22 | Complement deficiency (HP:0004431) | 3.79135203 |
| 23 | Tubulointerstitial abnormality (HP:0001969) | 3.78321402 |
| 24 | Glomerulonephritis (HP:0000099) | 3.72116217 |
| 25 | Ulnar bowing (HP:0003031) | 3.70095278 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 3.65711261 |
| 27 | Visceral angiomatosis (HP:0100761) | 3.56017804 |
| 28 | Tubulointerstitial nephritis (HP:0001970) | 3.54142608 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.49622939 |
| 30 | Alveolar cell carcinoma (HP:0006519) | 3.45307136 |
| 31 | Cerebral inclusion bodies (HP:0100314) | 3.44842421 |
| 32 | Hemangiomatosis (HP:0007461) | 3.34951437 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.32564433 |
| 34 | Nasal polyposis (HP:0100582) | 3.31083816 |
| 35 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.20473017 |
| 36 | Abnormality of complement system (HP:0005339) | 3.12664607 |
| 37 | Long toe (HP:0010511) | 3.10286241 |
| 38 | Broad metatarsal (HP:0001783) | 3.08933235 |
| 39 | Esophageal varix (HP:0002040) | 3.06716482 |
| 40 | Abnormality of chloride homeostasis (HP:0011422) | 3.03897149 |
| 41 | Hypotension (HP:0002615) | 3.02826359 |
| 42 | Hyperaldosteronism (HP:0000859) | 2.93477208 |
| 43 | Thyroid-stimulating hormone excess (HP:0002925) | 2.84856816 |
| 44 | Chronic otitis media (HP:0000389) | 2.84836758 |
| 45 | Tubular atrophy (HP:0000092) | 2.76455374 |
| 46 | Bronchitis (HP:0012387) | 2.75108007 |
| 47 | Cerebral aneurysm (HP:0004944) | 2.68989153 |
| 48 | Osteolytic defects of the hand bones (HP:0009699) | 2.67430495 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.67430495 |
| 50 | Neonatal respiratory distress (HP:0002643) | 2.58884887 |
| 51 | Bowing of the arm (HP:0006488) | 2.55972266 |
| 52 | Bowed forearm bones (HP:0003956) | 2.55972266 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.52020128 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.49919136 |
| 55 | Stomach cancer (HP:0012126) | 2.49096063 |
| 56 | Increased purine levels (HP:0004368) | 2.48897980 |
| 57 | Hyperuricemia (HP:0002149) | 2.48897980 |
| 58 | Loss of speech (HP:0002371) | 2.47173698 |
| 59 | Fragile nails (HP:0001808) | 2.43134966 |
| 60 | Conjunctival telangiectasia (HP:0000524) | 2.41222302 |
| 61 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.38864775 |
| 62 | Single umbilical artery (HP:0001195) | 2.38864775 |
| 63 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.38864775 |
| 64 | Vascular tortuosity (HP:0004948) | 2.37530254 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.37333640 |
| 66 | Potter facies (HP:0002009) | 2.36551910 |
| 67 | Facial shape deformation (HP:0011334) | 2.36551910 |
| 68 | Glomerulosclerosis (HP:0000096) | 2.36099318 |
| 69 | Milia (HP:0001056) | 2.34543271 |
| 70 | Bronchomalacia (HP:0002780) | 2.27711634 |
| 71 | Subacute progressive viral hepatitis (HP:0006572) | 2.24222155 |
| 72 | Pulmonary hypertension (HP:0002092) | 2.23149149 |
| 73 | Atrophic scars (HP:0001075) | 2.22484357 |
| 74 | Recurrent sinusitis (HP:0011108) | 2.19691878 |
| 75 | Aortic aneurysm (HP:0004942) | 2.17059181 |
| 76 | Glucose intolerance (HP:0000833) | 2.16260250 |
| 77 | Chronic sinusitis (HP:0011109) | 2.15044985 |
| 78 | Recurrent otitis media (HP:0000403) | 2.14936739 |
| 79 | Deep venous thrombosis (HP:0002625) | 2.13329936 |
| 80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09461948 |
| 81 | Cerebral hemorrhage (HP:0001342) | 2.09362009 |
| 82 | Decreased circulating renin level (HP:0003351) | 2.09316475 |
| 83 | Growth hormone excess (HP:0000845) | 2.07526275 |
| 84 | Pulmonary fibrosis (HP:0002206) | 2.06509682 |
| 85 | Hyponatremia (HP:0002902) | 2.06267248 |
| 86 | Infertility (HP:0000789) | 2.06258797 |
| 87 | Shallow orbits (HP:0000586) | 2.05789748 |
| 88 | Stenosis of the external auditory canal (HP:0000402) | 2.04301321 |
| 89 | Pustule (HP:0200039) | 2.03594944 |
| 90 | Male infertility (HP:0003251) | 2.03288492 |
| 91 | Striae distensae (HP:0001065) | 2.02359394 |
| 92 | Rapidly progressive (HP:0003678) | 2.00508673 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 14.1023949 |
| 94 | Turricephaly (HP:0000262) | 1.99018619 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94329498 |
| 96 | Abnormality of macrophages (HP:0004311) | 1.92544712 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.91895780 |
| 98 | Eczematoid dermatitis (HP:0000976) | 1.90291593 |
| 99 | Atelectasis (HP:0100750) | 1.89869133 |
| 100 | Shawl scrotum (HP:0000049) | 1.88784523 |
| 101 | Megalencephaly (HP:0001355) | 1.86788605 |
| 102 | Synostosis involving the elbow (HP:0003938) | 1.85567356 |
| 103 | Humeroradial synostosis (HP:0003041) | 1.85567356 |
| 104 | Right ventricular cardiomyopathy (HP:0011663) | 1.85092129 |
| 105 | Aplasia of the phalanges of the hand (HP:0009802) | 1.84475882 |
| 106 | Aplasia involving bones of the extremities (HP:0009825) | 1.84475882 |
| 107 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.84475882 |
| 108 | Hyperpituitarism (HP:0010514) | 1.81222559 |
| 109 | Hypokalemic alkalosis (HP:0001949) | 1.79133585 |
| 110 | Neoplasm of the lung (HP:0100526) | 1.78354011 |
| 111 | Abnormality of the dental pulp (HP:0006479) | 1.77731269 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.75486091 |
| 113 | Microcytic anemia (HP:0001935) | 1.74906777 |
| 114 | Plantar hyperkeratosis (HP:0007556) | 1.74818749 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 1.73375458 |
| 116 | Rectal prolapse (HP:0002035) | 1.73219488 |
| 117 | Aortic dissection (HP:0002647) | 1.71951578 |
| 118 | Hypoplasia of dental enamel (HP:0006297) | 1.71017153 |
| 119 | Camptodactyly of toe (HP:0001836) | 1.71012251 |
| 120 | Subcapsular cataract (HP:0000523) | 1.70162380 |
| 121 | Bronchiectasis (HP:0002110) | 1.69307812 |
| 122 | Exertional dyspnea (HP:0002875) | 1.69179116 |
| 123 | Prolonged neonatal jaundice (HP:0006579) | 1.68763282 |
| 124 | Nephritis (HP:0000123) | 1.67735773 |
| 125 | Split foot (HP:0001839) | 1.67657489 |
| 126 | Stage 5 chronic kidney disease (HP:0003774) | 1.66563113 |
| 127 | Vascular calcification (HP:0004934) | 1.66242373 |
| 128 | Recurrent bronchitis (HP:0002837) | 1.65530395 |
| 129 | Ankle contracture (HP:0006466) | 1.63531877 |
| 130 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.62134657 |
| 131 | Abnormality of the 2nd finger (HP:0004100) | 1.61538919 |
| 132 | Lip pit (HP:0100267) | 1.60433232 |
| 133 | Broad distal phalanx of finger (HP:0009836) | 1.59656612 |
| 134 | Abnormality of the gastric mucosa (HP:0004295) | 1.58124443 |
| 135 | Abnormality of sodium homeostasis (HP:0010931) | 1.57875903 |
| 136 | Adrenal overactivity (HP:0002717) | 1.57840537 |
| 137 | Thickened helices (HP:0000391) | 1.57215952 |
| 138 | Increased CSF protein (HP:0002922) | 1.57185687 |
| 139 | Progressive sensorineural hearing impairment (HP:0000408) | 1.56123664 |
| 140 | Dehydration (HP:0001944) | 1.55634562 |
| 141 | Cavernous hemangioma (HP:0001048) | 1.55493293 |
| 142 | Aneurysm (HP:0002617) | 1.55050917 |
| 143 | Arterial tortuosity (HP:0005116) | 1.55001610 |
| 144 | Abnormal glucose tolerance (HP:0001952) | 1.54825800 |
| 145 | Mitral stenosis (HP:0001718) | 1.54088149 |
| 146 | Cone-rod dystrophy (HP:0000548) | 1.53562887 |
| 147 | Cardiovascular calcification (HP:0011915) | 1.50460520 |
| 148 | Bell-shaped thorax (HP:0001591) | 1.48552563 |
| 149 | Neoplasm of the respiratory system (HP:0100606) | 1.47418499 |
| 150 | Abnormality of the dental root (HP:0006486) | 1.46591428 |
| 151 | Taurodontia (HP:0000679) | 1.46591428 |
| 152 | Abnormality of permanent molar morphology (HP:0011071) | 1.46591428 |
| 153 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.45872934 |
| 154 | Portal hypertension (HP:0001409) | 1.45029431 |
| 155 | Abnormality of renal excretion (HP:0011036) | 1.40077517 |
| 156 | Abnormality of molar (HP:0011077) | 1.39432734 |
| 157 | Abnormality of molar morphology (HP:0011070) | 1.39432734 |
| 158 | Distal lower limb muscle weakness (HP:0009053) | 1.39281633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.19471255 |
| 2 | FGFR2 | 4.72262999 |
| 3 | STK24 | 4.11855683 |
| 4 | LRRK2 | 3.20610905 |
| 5 | TGFBR2 | 3.17786721 |
| 6 | TRIB3 | 2.73577768 |
| 7 | ZAP70 | 2.71282428 |
| 8 | RIPK1 | 2.45786354 |
| 9 | EPHA2 | 2.44845969 |
| 10 | EPHB1 | 2.41659869 |
| 11 | LATS1 | 2.38591481 |
| 12 | PAK4 | 2.37712704 |
| 13 | PDGFRB | 2.20118332 |
| 14 | MST4 | 2.09545099 |
| 15 | DAPK2 | 1.98497454 |
| 16 | LMTK2 | 1.96661591 |
| 17 | EPHB2 | 1.95703979 |
| 18 | NLK | 1.87680685 |
| 19 | CAMK1D | 1.85561325 |
| 20 | FGFR4 | 1.76497448 |
| 21 | STK10 | 1.74270965 |
| 22 | FER | 1.72516027 |
| 23 | ILK | 1.70199405 |
| 24 | MST1R | 1.63124512 |
| 25 | ERN1 | 1.57558709 |
| 26 | PTK6 | 1.56131493 |
| 27 | MAP3K2 | 1.47225768 |
| 28 | BCR | 1.45283139 |
| 29 | MAP3K3 | 1.44209914 |
| 30 | TRPM7 | 1.43131020 |
| 31 | CDC42BPA | 1.42736587 |
| 32 | GRK1 | 1.37811081 |
| 33 | IRAK1 | 1.28885153 |
| 34 | MAP3K9 | 1.28802694 |
| 35 | KSR2 | 1.28180986 |
| 36 | SIK1 | 1.27984294 |
| 37 | PDGFRA | 1.26101248 |
| 38 | MAPK15 | 1.23240801 |
| 39 | EPHA3 | 1.20474297 |
| 40 | MET | 1.16010611 |
| 41 | CAMK1G | 1.15247873 |
| 42 | TAOK3 | 1.15094349 |
| 43 | TESK1 | 1.10718116 |
| 44 | CDK6 | 1.07407077 |
| 45 | YES1 | 1.04445734 |
| 46 | GSK3A | 1.04209297 |
| 47 | FGFR3 | 1.03430284 |
| 48 | MYLK | 1.01966155 |
| 49 | MAP3K6 | 1.00854972 |
| 50 | NEK6 | 0.99920781 |
| 51 | LATS2 | 0.98270706 |
| 52 | MAPKAPK3 | 0.96449201 |
| 53 | STK3 | 0.95262016 |
| 54 | STK38L | 0.94761084 |
| 55 | NME1 | 0.92982236 |
| 56 | PKN2 | 0.89861985 |
| 57 | ERBB3 | 0.85847251 |
| 58 | HIPK2 | 0.85004430 |
| 59 | PTK2 | 0.83633007 |
| 60 | SGK2 | 0.82898710 |
| 61 | PRKD1 | 0.78745133 |
| 62 | CSK | 0.76652699 |
| 63 | MAP3K14 | 0.75910707 |
| 64 | DDR2 | 0.75272787 |
| 65 | EGFR | 0.75186926 |
| 66 | MAP3K13 | 0.71065527 |
| 67 | BRSK2 | 0.69733560 |
| 68 | TBK1 | 0.67658636 |
| 69 | KDR | 0.67609975 |
| 70 | PDPK1 | 0.64020210 |
| 71 | MAP2K2 | 0.63264782 |
| 72 | MAP2K3 | 0.62682551 |
| 73 | SGK494 | 0.61506092 |
| 74 | SGK223 | 0.61506092 |
| 75 | MELK | 0.61144470 |
| 76 | ERBB2 | 0.58879429 |
| 77 | TGFBR1 | 0.57965928 |
| 78 | EEF2K | 0.57696322 |
| 79 | FRK | 0.56136620 |
| 80 | MAPK7 | 0.56121644 |
| 81 | FGFR1 | 0.55301599 |
| 82 | NEK9 | 0.54413617 |
| 83 | MARK2 | 0.54057968 |
| 84 | PTK2B | 0.53111919 |
| 85 | MAP3K1 | 0.52604040 |
| 86 | KIT | 0.49207051 |
| 87 | TYRO3 | 0.48594357 |
| 88 | RET | 0.45189866 |
| 89 | MAP3K12 | 0.44746937 |
| 90 | RPS6KA4 | 0.43680391 |
| 91 | PRKCE | 0.43616495 |
| 92 | NTRK1 | 0.43411071 |
| 93 | MAP2K1 | 0.42590493 |
| 94 | BMX | 0.42550426 |
| 95 | MATK | 0.42490465 |
| 96 | ABL1 | 0.41101272 |
| 97 | LIMK1 | 0.40457853 |
| 98 | INSR | 0.40439652 |
| 99 | JAK1 | 0.40372170 |
| 100 | DMPK | 0.40130064 |
| 101 | STK39 | 0.38965987 |
| 102 | PRPF4B | 0.37740054 |
| 103 | MAP3K7 | 0.36800329 |
| 104 | PRKCQ | 0.34946459 |
| 105 | PRKG2 | 0.34710001 |
| 106 | ROCK1 | 0.34482573 |
| 107 | WNK4 | 0.33818430 |
| 108 | PRKCD | 0.33680409 |
| 109 | TYK2 | 0.32792645 |
| 110 | TTN | 0.31570893 |
| 111 | PDK2 | 0.31345621 |
| 112 | MAPK12 | 0.31237144 |
| 113 | MAPKAPK2 | 0.29200861 |
| 114 | AKT3 | 0.29011667 |
| 115 | SGK3 | 0.28396501 |
| 116 | TAOK1 | 0.28199127 |
| 117 | CHUK | 0.27914430 |
| 118 | ABL2 | 0.27659381 |
| 119 | DAPK3 | 0.27295572 |
| 120 | MAPK3 | 0.27025885 |
| 121 | BLK | 0.26922724 |
| 122 | MAP3K8 | 0.26893600 |
| 123 | ROCK2 | 0.26727438 |
| 124 | IGF1R | 0.26037512 |
| 125 | JAK2 | 0.25749882 |
| 126 | DAPK1 | 0.25706534 |
| 127 | FGR | 0.25362881 |
| 128 | IRAK3 | 0.22867531 |
| 129 | MTOR | 0.22838063 |
| 130 | PRKAA2 | 0.22423849 |
| 131 | STK38 | 0.22178190 |
| 132 | PRKCH | 0.21918544 |
| 133 | PDK4 | 0.21202536 |
| 134 | PDK3 | 0.21202536 |
| 135 | RPS6KA2 | 0.19585453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.26582708 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.05251440 |
| 3 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.10812273 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.41629515 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 2.37884263 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.11352536 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.08445899 |
| 8 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.02933300 |
| 9 | Tight junction_Homo sapiens_hsa04530 | 1.94846996 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91697650 |
| 11 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.84738751 |
| 12 | * Mineral absorption_Homo sapiens_hsa04978 | 1.80108372 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.77109026 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75453079 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73567194 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64070446 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.60507218 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.60311286 |
| 19 | Focal adhesion_Homo sapiens_hsa04510 | 1.54627069 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.54179395 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.50209464 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45926643 |
| 23 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.40182783 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.36177132 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.34319112 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34152582 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29941573 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.28639182 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25113323 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.25064547 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.25035857 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21399584 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21038149 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20738062 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17021035 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.16345769 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13475252 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11840365 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10263332 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.08956998 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08750950 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08069257 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08024945 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07395484 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02768590 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.02011540 |
| 47 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00668427 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00029230 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 0.99516646 |
| 50 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.99333629 |
| 51 | Endocytosis_Homo sapiens_hsa04144 | 0.97818392 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96823564 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96693551 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95892309 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95810732 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95789913 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95609036 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94672816 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93107554 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.92010700 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91609104 |
| 62 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.88171121 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87555752 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87119412 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86279271 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86130127 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85366214 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82975455 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82677653 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82623755 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82478897 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82010071 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81989445 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80451178 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79460881 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77974105 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77321555 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75168946 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.74663226 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.72973497 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72914725 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71141018 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.70670613 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68622205 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68488635 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68324454 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.67589773 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66845225 |
| 89 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66466463 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64002315 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63274502 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.63075701 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62996397 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.62773946 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.62721406 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61116508 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60989706 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.59688803 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.58041110 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57990429 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57370857 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57237484 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56674979 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56080173 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55759591 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55319122 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53698438 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53402582 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51967592 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51623311 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49227537 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48943127 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48240746 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48119661 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.47446159 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47377977 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46600719 |
| 118 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45945078 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44818148 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.44579194 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.43841337 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43819237 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.43496357 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43179416 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.43108240 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42163714 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41841488 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41769823 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41453487 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41365220 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40752412 |
| 132 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40690715 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40333569 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38771815 |
| 135 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37575482 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35829357 |

